Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 22:10:43.
doi: 10.1186/1477-7525-10-43.

Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health

Affiliations

Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health

Roxanna M Bendixen et al. Health Qual Life Outcomes. .

Abstract

Background: Duchenne muscular dystrophy (DMD) is characterized by muscle damage and progressive loss of muscle function in male children. DMD is one of the most devastating genetically linked neuromuscular diseases for which there is currently no cure. Most clinical studies for DMD utilize a standard protocol for measurement exploring pathophysiology, muscle strength and timed tasks. However, we propose that examining broader components of health as emphasized by the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY) may be of great value to children and their families, and important outcomes for future clinical trials.

Methods: Fifty boys with DMD and 25 unaffected age-matched boys completed two self-report measures: the Children's Assessment of Participation and Enjoyment and the Pediatric Quality of Life InventoryTM 4.0. We investigated differences between the two groups with regard to participation in life activities and perceived quality of life (QoL). Additionally, we compared participation in activities and QoL in both cohorts of younger and older boys.

Results: Participation in physical activities was significantly lower in boys with DMD than unaffected boys. Perceived QoL was markedly diminished in children with DMD relative to unaffected controls, except in the emotional domain. The amount of time boys engage in an activity, as well as participation in social activities, declined for our older boys with DMD but no changes were observed for our older unaffected boys. For both groups, QoL remained constant over time.

Conclusions: The ICF-CY provides a conceptual framework and specific terminology that facilitates investigation of the consequences of impairment in children and youth. Our study is one of the first to explore participation in a cohort of boys with DMD. It was not surprising that activities of choice for boys with DMD were less physical in nature than unaffected boys their age, but the consequences of less social engagement as the boys with DMD age is of great concern. Results from our study underscore the need to further evaluate activities that children elect to participate in, with special emphasis on facilitators and barriers to participation and how participation changes throughout the course of a disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY).
Figure 2
Figure 2
Baseline CAPE Responses by DMD (n = 50) and Unaffected Age-Matched Subjects (n = 25). CAPE, Children’s Assessment of Participation and Enjoyment collection instrument. DMD, Duchenne muscular dystrophy; Range of scores (Intensity 0–7; Physical Activities 0–7; Recreational Activities 0–7; Social Activities 0–7). Data are presented as means ± standard deviations. ***p <0. 001.
Figure 3
Figure 3
Baseline PedsQL Responses by DMD (n = 50) and Unaffected Age-Matched Subjects (n = 25) . DMD, Duchenne muscular dystrophy; PedsQLTM, Pediatric Quality of Life collection instrument; Range of scores 0–100. Data are presented as means ± standard deviations. *p <0.05; **p < 0.01; ***p < 0.001.

References

    1. Deconinck N, Dan B. Pathophysiology of Duchenne muscular dystrophy. Pediatr Neurol. 2007;36(1):1–7. doi: 10.1016/j.pediatrneurol.2006.09.016. - DOI - PubMed
    1. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919–928. doi: 10.1016/0092-8674(87)90579-4. - DOI - PubMed
    1. Sussman M. Duchenne muscular dystrophy. J Ame Acad Orthop Surg. 2002;10(2):138–151. - PubMed
    1. Tidball JG, Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol. 2007;102(4):1677–1686. - PubMed
    1. Emery A, Muntoni F. Duchenne Muscular Dystrophy. 3. Oxford University Press, Oxford; 2003.

Publication types

MeSH terms